Brechas y desafíos en la evaluación de la hematuria microscópica en atención primaria
Contenido principal del artículo
Resumen
Journal Club
Descargas
Detalles del artículo
Citas en Dimensions Service
Citas
An C, Jeong J, Chiu C, Gaston E, Kennedy A, Sternberg K. Risk stratification and diagnostic evaluation of patients found to have microscopic hematuria by their primary care providers. J Gen Fam Med. 2025;26(1):73–78.
Lippmann QK, Slezak JM, Menefee SA, Ng CK, Whitcomb EL, Loo RK. Evaluation of microscopic hematuria and risk of urologic cancer in female patients. Am J Obstet Gynecol. 2017;216(2):146. e1-146.e7.
Barocas DA, Boorjian SA, Alvarez RD, Downs TM, Gross CP, Hamilton BD, et al. Microhematuria: AUA/SUFU Guideline. J. Urol. 2020;204(4):778–786.
Schmidt-Hansen M, Hamilton W. The NICE primary care referral guideline for suspected bladder or renal cancer. Trend Urol Mens Heal. 2016;7(2):21–24.
Gold SA, Kenigsberg AP, Lotan Y. Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System. J. Urol. 2022;207(1):52–59.
Bochner E, Ibezue C, Banerji D, Attia S, Taylor J, Lotan Y. Assessing the Diagnostic Performance of Renal Ultrasound in Microhematuria Evaluation: Validation of the AUA Microhematuria 2020 Guidelines. Urology. 2025:S0090-4295(25)00881-7.

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.